Key Trends Influencing the Growth of the D Dimer Testing Market in 2025: Strategic Partnerships Drive Advancements In The D-Dimer Testing Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the D Dimer Testing Market Through 2025?
The market size for D dimer testing has seen consistent expansion in the preceding years. Its growth trajectory indicates an increase from $1.47 billion in 2024 to $1.54 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. The historically observed growth can be credited to the advancement in thrombosis research, refinement of laboratory methods, clinical confirmation of d-dimer as an indicator, and alterations in diagnostic procedures.

What's the Projected Size of the Global D Dimer Testing Market by 2029?
The market for D dimer testing is projected to experience substantial growth in the forthcoming years, expected to reach $1.9 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 5.4%. This increase during the forecasted period is believed to be driven by factors including a rising elderly population, growth in point-of-care testing (POCT), integration with risk assessment algorithms, a boost in awareness and education programs, as well as regulatory guidance and normalization. Key trends for the projected period encompass enhancing diagnosis through biomarker combinations, focusing on quick and precise results, the role of d-dimer testing in managing COVID-19, home-based test kits and remote monitoring, and consistent monitoring along with serial testing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Top Growth Drivers in the D Dimer Testing Industry: What's Accelerating the Market?
The rise in cancer incidence is forecasted to fuel the expansion of the d-dimer testing market. Cancer refers to a group of diseases that can form almost anywhere in the body when unusual cells grow uncontrollably, break down their normal barriers, and either migrate to other organs or invade adjacent tissues. D-dimer testing is primarily utilized to aid diagnosis, surveillance, and treatment of cancer patients and to evaluate the likelihood of blood clot formation. It checks for thrombotic occurrences in various medical situations. For example, a study conducted in January 2022 by the American Cancer Society, a health organization based in the US, projected 609,360 cancer-related deaths and 1.9 million new cancer cases in the US for the year 2022. This is equivalent to nearly 1,670 deaths per day. Therefore, the growing incidence of cancer is propelling the expansion of the d-dimer testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

What Trends Will Shape the D Dimer Testing Market Through 2029 and Beyond?
Key players in the D-dimer testing market are strategically partnering to secure exclusive rights to D-dimer testing solutions, aiming to gain a competitive edge. These strategic partnerships involve businesses exploiting each other's capabilities and resources for mutual success and benefit. A case in point from March 2022 involves SphingoTec GmbH, a biotechnology firm based in Germany, forming an alliance with Rivaara Labs Pvt Ltd., a medical laboratory and healthcare enterprise based in India. This collaboration provides Rivaara with exclusive marketing and distribution rights for SphingoTec's point-of-care tests highlighting innovative biomarkers in the Indian subcontinent. These biomarkers include proenkephalin (penKid) for kidney function measure, bioactive adrenomedullin (bio-ADM) for evaluating endothelial function, and dipeptidyl peptidase 3 (DPP3) as a cardiac depression biomarker. These cutting-edge markers are in addition to commonly used parameters such as procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.

What Are the Main Segments in the D Dimer Testing Market?
The D dimer testing market covered in this report is segmented -

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests
2) By Product: Analyzers, Reagents And Consumables
3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method
4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application
5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User

Subsegments:
1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays, Other Laboratory Testing Methods
2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays, Other Point-Of-Care Testing Methods

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12341&type=smp

Which Top Companies are Driving Growth in the D Dimer Testing Market?
Major companies operating in the D dimer testing market include Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

Which Regions Will Dominate the D Dimer Testing Market Through 2029?
North America was the largest region in the D dimer testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the D dimer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12341

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.